Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Dyax Corp. (NASDAQ:DYAX), Hatteras Financial Corp. (NYSE:HTS), Mack Cali Realty Corp (NYSE:CLI)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) managed to keep its fall at -3.86% on below -normal volume of 1.63M shares. The stock settled at $3.24 after floating in a range of $3.18 to $3.39. Its latest price has reached market capitalization of $313.12 million. Its 52-week range has been $2.26 to $10.17. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Has ACHN Found The Bottom and Ready To Move Up? Find Out Here
Dyax Corp. (NASDAQ:DYAX) traded up on a volume of 1.62 million, lower than its standard daily volume. Shares have gained 0.99% to $8.19. Over the last twelve months, the stock has gained 164.19% and faced a worst price of $2.26. Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program. It is focused on identifying and developing treatments for patients who experience plasma kallikrein (bradykinin) mediated angioedema.
For How Long DYAX’s Gloss will Attract Investors? Find out via this report
Hatteras Financial Corp. (NYSE:HTS) settled 1.62% higher at $16.91on above-normal volume of 1.58M shares during the last trading day. The stock has its 12-month high at $28.28 and 52-week low price was $16.21. It traded in a range of $16.61 to $17.06 during the last trading day. Hatteras Financial Corp. is an externally managed mortgage real estate investment trust (REIT) that invests primarily in single-family residential mortgage pass-through securities guaranteed or issued by the United States Government agency (such as the Government National Mortgage Association (Ginnie Mae)), or by the United States Government-sponsored entity (such as the Federal National Mortgage Association, (Fannie Mae)), and the Federal Home Loan Mortgage Corporation, (Freddie Mac)).
Why Should Investors Buy HTS After the Recent Fall? Just Go Here and Find Out
In the last trading session, Mack Cali Realty Corp (NYSE:CLI) showed no change on high volume, trading at a volume of 1.62M shares versus its average daily volume of 876,480.00 shares. At $21.13, the stock has attained market capitalization of $1.86 billion. Mack-Cali Realty Corporation is a self-administered and self-managed real estate investment trust (REIT), which owns and operates a real estate portfolios consisted of Class A office and office/flex properties located in the Northeast. In January 2013, it acquired Alterra at Overlook Ridge IA in Metro Boston. In March 2013, it acquired the 828-unit multi-family property known as Crystal House in the Crystal City section of Arlington, Virginia. In April 2013, it acquired Alterra at Overlook Ridge IB in Metro Boston. In April 2013, the Company sold its 55 Corporate Drive office building located in Bridgewater, New Jersey.
Can CLI Show a Strong Recovery? Find out in This Research Report
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)